139 related articles for article (PubMed ID: 12211142)
1. DA agonists -- ergot derivatives: cabergoline: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S68-71. PubMed ID: 12211142
[No Abstract] [Full Text] [Related]
2. DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S53-67. PubMed ID: 12211141
[No Abstract] [Full Text] [Related]
3. DA agonists -- ergot derivatives: dihydroergocryptine (DHEC): management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S72-3. PubMed ID: 12211143
[No Abstract] [Full Text] [Related]
4. DA agonists -- ergot derivatives: pergolide: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S79-82. PubMed ID: 12211145
[No Abstract] [Full Text] [Related]
5. DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S74-8. PubMed ID: 12211144
[No Abstract] [Full Text] [Related]
6. Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists.
Simonis G; Fuhrmann JT; Strasser RH
Mov Disord; 2007 Oct; 22(13):1936-42. PubMed ID: 17659636
[TBL] [Abstract][Full Text] [Related]
7. Cabergoline in Parkinson's disease complicated by motor fluctuations.
Geminiani G; Fetoni V; Genitrini S; Giovannini P; Tamma F; Caraceni T
Mov Disord; 1996 Sep; 11(5):495-500. PubMed ID: 8866490
[TBL] [Abstract][Full Text] [Related]
8. DA agonists -- non-ergot derivatives: ropinirole: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S98-102. PubMed ID: 12211149
[No Abstract] [Full Text] [Related]
9. DA agonists -- non-ergot derivatives: piribedil: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S90-2. PubMed ID: 12211147
[No Abstract] [Full Text] [Related]
10. Treatment of Parkinson's disease and restless legs syndrome with cabergoline, a long-acting dopamine agonist.
Porter MC; Appiah-Kubf LS; Chaudhuri KR
Int J Clin Pract; 2002; 56(6):468-74. PubMed ID: 12166546
[TBL] [Abstract][Full Text] [Related]
11. DA agonists -- non-ergot derivatives: pramipexole: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S93-7. PubMed ID: 12211148
[No Abstract] [Full Text] [Related]
12. DA agonists -- non-ergot derivatives: apomorphine: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S83-9. PubMed ID: 12211146
[No Abstract] [Full Text] [Related]
13. Ergot and non-ergot dopamine agonists and heart failure in patients with Parkinson's disease.
Montastruc F; Moulis F; Araujo M; Chebane L; Rascol O; Montastruc JL
Eur J Clin Pharmacol; 2017 Jan; 73(1):99-103. PubMed ID: 27796464
[TBL] [Abstract][Full Text] [Related]
14. Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study.
Junghanns S; Fuhrmann JT; Simonis G; Oelwein C; Koch R; Strasser RH; Reichmann H; Storch A
Mov Disord; 2007 Jan; 22(2):234-8. PubMed ID: 17094087
[TBL] [Abstract][Full Text] [Related]
15. An evidence-based review of dopamine receptor agonists in the treatment of Parkinson's disease.
Deleu D; Northway MG; Hanssens Y
Saudi Med J; 2002 Oct; 23(10):1165-75. PubMed ID: 12436117
[TBL] [Abstract][Full Text] [Related]
16. Combination of two different dopamine agonists in the management of Parkinson's disease.
Stocchi F; Berardelli A; Vacca L; Thomas A; De Pandis MF; Modugno N; Valente M; Ruggieri S
Neurol Sci; 2002 Sep; 23 Suppl 2():S115-6. PubMed ID: 12548370
[TBL] [Abstract][Full Text] [Related]
17. Cabergoline can increase penile erections and libido.
Wittstock M; Benecke R; Dressler D
Neurology; 2002 Mar; 58(5):831. PubMed ID: 11889258
[No Abstract] [Full Text] [Related]
18. Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists.
Horvath J; Fross RD; Kleiner-Fisman G; Lerch R; Stalder H; Liaudat S; Raskoff WJ; Flachsbart KD; Rakowski H; Pache JC; Burkhard PR; Lang AE
Mov Disord; 2004 Jun; 19(6):656-62. PubMed ID: 15197703
[TBL] [Abstract][Full Text] [Related]
19. Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease.
Inzelberg R; Nisipeanu P; Rabey MJ; Korczyn AD
Mov Disord; 1995 Sep; 10(5):604-7. PubMed ID: 8552112
[TBL] [Abstract][Full Text] [Related]
20. Prescribing pattern of anti-Parkinson drugs in Japan: a trend analysis from 2005 to 2010.
Nakaoka S; Ishizaki T; Urushihara H; Satoh T; Ikeda S; Yamamoto M; Nakayama T
PLoS One; 2014; 9(6):e99021. PubMed ID: 24906013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
